SGLT2 inhibitors optimal drug class for heart failure with preserved and mildly reduced ejection fraction

SGLT2 inhibitors optimal drug class for heart failure with preserved and mildly reduced ejection fraction is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or .

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

There's more to see -- the rest of this topic is available only to subscribers.